john bell & croyden limited Company Information
Company Number
00228331
Website
www.johnbellcroyden.co.ukRegistered Address
merchants warehouse, castle street, manchester, M3 4LZ
Industry
Dispensing chemist in specialised stores
Telephone
02079355555
Next Accounts Due
December 2024
Group Structure
View All
Shareholders
admenta holdings limited 100%
john bell & croyden limited Estimated Valuation
Pomanda estimates the enterprise value of JOHN BELL & CROYDEN LIMITED at £4.4m based on a Turnover of £11.5m and 0.39x industry multiple (adjusted for size and gross margin).
john bell & croyden limited Estimated Valuation
Pomanda estimates the enterprise value of JOHN BELL & CROYDEN LIMITED at £10.2m based on an EBITDA of £1.9m and a 5.35x industry multiple (adjusted for size and gross margin).
john bell & croyden limited Estimated Valuation
Pomanda estimates the enterprise value of JOHN BELL & CROYDEN LIMITED at £13.7m based on Net Assets of £6m and 2.27x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
John Bell & Croyden Limited AI Business Plan
In just minutes, we combine Pomanda’s company and industry data with cutting edge Artificial Intelligence to build a comprehensive 27 section business plan. You then have 60 days to tailor the information, decide which sections to include or exclude, and add your own branding logos, images and color scheme to create your perfect plan.
John Bell & Croyden Limited Overview
John Bell & Croyden Limited is a live company located in manchester, M3 4LZ with a Companies House number of 00228331. It operates in the dispensing chemist in specialised stores sector, SIC Code 47730. Founded in February 1928, it's largest shareholder is admenta holdings limited with a 100% stake. John Bell & Croyden Limited is a mature, mid sized company, Pomanda has estimated its turnover at £11.5m with declining growth in recent years.
Upgrade for unlimited company reports & a free credit check
John Bell & Croyden Limited Health Check
Pomanda's financial health check has awarded John Bell & Croyden Limited a 5 rating. We use a traffic light system to show it exceeds the industry average on 4 measures and has 2 areas for improvement. Company Health Check FAQs
4 Strong
5 Regular
2 Weak
Size
annual sales of £11.5m, make it in line with the average company (£12.1m)
£11.5m - John Bell & Croyden Limited
£12.1m - Industry AVG
Growth
3 year (CAGR) sales growth of -3%, show it is growing at a slower rate (5.4%)
-3% - John Bell & Croyden Limited
5.4% - Industry AVG
Production
with a gross margin of 45.8%, this company has a lower cost of product (31.7%)
45.8% - John Bell & Croyden Limited
31.7% - Industry AVG
Profitability
an operating margin of 6.6% make it more profitable than the average company (3.4%)
6.6% - John Bell & Croyden Limited
3.4% - Industry AVG
Employees
with 83 employees, this is similar to the industry average (85)
83 - John Bell & Croyden Limited
85 - Industry AVG
Pay Structure
on an average salary of £26.3k, the company has an equivalent pay structure (£22k)
£26.3k - John Bell & Croyden Limited
£22k - Industry AVG
Efficiency
resulting in sales per employee of £138.2k, this is equally as efficient (£139.2k)
£138.2k - John Bell & Croyden Limited
£139.2k - Industry AVG
Debtor Days
it gets paid by customers after 10 days, this is earlier than average (31 days)
10 days - John Bell & Croyden Limited
31 days - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- - John Bell & Croyden Limited
- - Industry AVG
Stock Days
it holds stock equivalent to 64 days, this is more than average (30 days)
64 days - John Bell & Croyden Limited
30 days - Industry AVG
Cash Balance
has cash to cover current liabilities for 14 weeks, this is average cash available to meet short term requirements (15 weeks)
14 weeks - John Bell & Croyden Limited
15 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 17.3%, this is a lower level of debt than the average (61.9%)
17.3% - John Bell & Croyden Limited
61.9% - Industry AVG
john bell & croyden limited Credit Report and Business Information
John Bell & Croyden Limited Competitor Analysis
Perform a competitor analysis for john bell & croyden limited by selecting its closest rivals and benchmarking them against 12 key performance metrics.
john bell & croyden limited Ownership
JOHN BELL & CROYDEN LIMITED group structure
John Bell & Croyden Limited has no subsidiary companies.
Ultimate parent company
AURELIUS INVESTMENT LUX ONE SARL
#0143598
2 parents
JOHN BELL & CROYDEN LIMITED
00228331
john bell & croyden limited directors
John Bell & Croyden Limited currently has 4 directors. The longest serving directors include Ms Wendy Hall (Jul 2022) and Miss Katherine Jacob (Jul 2023).
officer | country | age | start | end | role |
---|---|---|---|---|---|
Ms Wendy Hall | England | 53 years | Jul 2022 | - | Director |
Miss Katherine Jacob | England | 46 years | Jul 2023 | - | Director |
Mr Sebastian Hobbs | England | 55 years | Jul 2023 | - | Director |
Mr Andrew Caplan | England | 56 years | Aug 2023 | - | Director |
JOHN BELL & CROYDEN LIMITED financials
John Bell & Croyden Limited's latest turnover from March 2023 is £11.5 million and the company has net assets of £6 million. According to their latest financial statements, John Bell & Croyden Limited has 83 employees and maintains cash reserves of £343 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Turnover | 11,467,000 | 8,869,000 | 6,858,000 | 12,401,000 | 12,903,000 | 12,028,000 | 10,880,000 | 9,055,000 | 12,232,000 | 8,948,000 | 8,872,000 | 8,815,000 | 9,792,000 | 10,795,000 |
Other Income Or Grants | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cost Of Sales | 6,213,000 | 5,174,000 | 4,234,000 | 7,100,000 | 7,832,000 | 7,378,000 | 6,622,000 | 6,487,000 | 7,357,000 | 5,969,000 | 5,757,000 | 5,467,000 | 6,444,000 | 7,271,000 |
Gross Profit | 5,254,000 | 3,695,000 | 2,624,000 | 5,301,000 | 5,071,000 | 4,650,000 | 4,258,000 | 2,568,000 | 4,875,000 | 2,979,000 | 3,115,000 | 3,348,000 | 3,348,000 | 3,524,000 |
Admin Expenses | 4,494,000 | 3,390,000 | 3,724,000 | 3,213,000 | 5,123,000 | 3,952,000 | 3,522,000 | 3,682,000 | 3,644,000 | 2,920,000 | 3,211,000 | 2,866,000 | 2,908,000 | 2,915,000 |
Operating Profit | 760,000 | 305,000 | -1,100,000 | 2,088,000 | -52,000 | 698,000 | 736,000 | -1,114,000 | 1,231,000 | 59,000 | -96,000 | 482,000 | 440,000 | 609,000 |
Interest Payable | 41,000 | 53,000 | 64,000 | 36,000 | 0 | 0 | 0 | 36,000 | 45,000 | 36,000 | 36,000 | 39,000 | 36,000 | 36,000 |
Interest Receivable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Pre-Tax Profit | 719,000 | 252,000 | -1,164,000 | 2,052,000 | -88,000 | 662,000 | 700,000 | -1,150,000 | 1,186,000 | 23,000 | -132,000 | 443,000 | 404,000 | 573,000 |
Tax | 201,000 | -261,000 | 148,000 | -407,000 | -42,000 | -131,000 | -202,000 | 217,000 | -202,000 | -17,000 | 12,000 | -131,000 | -127,000 | -174,000 |
Profit After Tax | 920,000 | -9,000 | -1,016,000 | 1,645,000 | -130,000 | 531,000 | 498,000 | -933,000 | 984,000 | 6,000 | -120,000 | 312,000 | 277,000 | 399,000 |
Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Retained Profit | 920,000 | -9,000 | -1,016,000 | 1,645,000 | -130,000 | 531,000 | 498,000 | -933,000 | 984,000 | 6,000 | -120,000 | 312,000 | 277,000 | 399,000 |
Employee Costs | 2,185,000 | 1,947,000 | 1,924,000 | 2,182,000 | 2,295,000 | 2,145,000 | 1,945,000 | 1,768,000 | 2,017,000 | 2,144,000 | 1,733,000 | 1,481,000 | 1,560,000 | 1,634,000 |
Number Of Employees | 83 | 75 | 81 | 97 | 102 | 97 | 94 | 87 | 84 | 92 | 81 | 77 | 70 | 78 |
EBITDA* | 1,908,000 | 2,038,000 | -302,000 | 2,222,000 | 394,000 | 1,116,000 | 1,142,000 | -776,000 | 1,417,000 | 200,000 | 39,000 | 595,000 | 595,000 | 778,000 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Tangible Assets | 992,000 | 2,041,000 | 3,086,000 | 2,452,000 | 1,637,000 | 2,631,000 | 2,921,000 | 3,285,000 | 553,000 | 633,000 | 715,000 | 780,000 | 151,000 | 302,000 |
Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Fixed Assets | 992,000 | 2,041,000 | 3,086,000 | 2,452,000 | 1,637,000 | 2,631,000 | 2,921,000 | 3,285,000 | 553,000 | 633,000 | 715,000 | 780,000 | 151,000 | 302,000 |
Stock & work in progress | 1,095,000 | 792,000 | 964,000 | 1,130,000 | 1,234,000 | 1,168,000 | 1,474,000 | 1,310,000 | 1,255,000 | 1,146,000 | 1,060,000 | 972,000 | 1,123,000 | 1,118,000 |
Trade Debtors | 329,000 | 151,000 | 47,000 | 220,000 | 1,096,000 | 603,000 | 489,000 | 212,000 | 245,000 | 259,000 | 325,000 | 319,000 | 350,000 | 421,000 |
Group Debtors | 4,514,000 | 0 | 0 | 0 | 177,000 | 176,000 | 0 | 0 | 0 | 0 | 0 | 3,015,000 | 3,120,000 | 2,646,000 |
Misc Debtors | 1,000 | 77,000 | 104,000 | 90,000 | 119,000 | 41,000 | 85,000 | 214,000 | 24,000 | 903,000 | 10,000 | 8,000 | 4,000 | 0 |
Cash | 343,000 | 24,370,000 | 22,999,000 | 21,169,000 | 18,118,000 | 15,148,000 | 12,216,000 | 10,783,000 | 8,265,000 | 5,215,000 | 3,025,000 | 11,000 | 9,000 | 8,000 |
misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total current assets | 6,282,000 | 25,390,000 | 24,114,000 | 22,609,000 | 20,744,000 | 17,136,000 | 14,264,000 | 12,519,000 | 9,789,000 | 7,523,000 | 4,420,000 | 4,325,000 | 4,606,000 | 4,193,000 |
total assets | 7,274,000 | 27,431,000 | 27,200,000 | 25,061,000 | 22,381,000 | 19,767,000 | 17,185,000 | 15,804,000 | 10,342,000 | 8,156,000 | 5,135,000 | 5,105,000 | 4,757,000 | 4,495,000 |
Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Trade Creditors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Group/Directors Accounts | 0 | 20,654,000 | 0 | 18,003,000 | 17,235,000 | 14,651,000 | 12,669,000 | 11,336,000 | 5,012,000 | 2,840,000 | 259,000 | 0 | 0 | 0 |
other short term finances | 635,000 | 635,000 | 0 | 635,000 | 635,000 | 635,000 | 635,000 | 635,000 | 635,000 | 635,000 | 635,000 | 635,000 | 635,000 | 635,000 |
hp & lease commitments | 54,000 | 886,000 | 802,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other current liabilities | 516,000 | 107,000 | 20,721,000 | 471,000 | 254,000 | 52,000 | 25,000 | 475,000 | 404,000 | 1,015,000 | 940,000 | 1,049,000 | 1,013,000 | 1,024,000 |
total current liabilities | 1,205,000 | 22,282,000 | 21,523,000 | 19,109,000 | 18,124,000 | 15,338,000 | 13,329,000 | 12,446,000 | 6,051,000 | 4,490,000 | 1,834,000 | 1,684,000 | 1,648,000 | 1,659,000 |
loans | 0 | 0 | 1,520,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
hp & lease commitments | 0 | 0 | 760,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
provisions | 50,000 | 50,000 | 100,000 | 50,000 | 0 | 42,000 | 0 | 0 | 0 | 359,000 | 0 | 0 | 0 | 4,000 |
total long term liabilities | 50,000 | 50,000 | 810,000 | 50,000 | 0 | 42,000 | 0 | 0 | 0 | 359,000 | 0 | 0 | 0 | 4,000 |
total liabilities | 1,255,000 | 22,332,000 | 22,333,000 | 19,159,000 | 18,124,000 | 15,380,000 | 13,329,000 | 12,446,000 | 6,051,000 | 4,849,000 | 1,834,000 | 1,684,000 | 1,648,000 | 1,663,000 |
net assets | 6,019,000 | 5,099,000 | 4,867,000 | 5,902,000 | 4,257,000 | 4,387,000 | 3,856,000 | 3,358,000 | 4,291,000 | 3,307,000 | 3,301,000 | 3,421,000 | 3,109,000 | 2,832,000 |
total shareholders funds | 6,019,000 | 5,099,000 | 4,867,000 | 5,902,000 | 4,257,000 | 4,387,000 | 3,856,000 | 3,358,000 | 4,291,000 | 3,307,000 | 3,301,000 | 3,421,000 | 3,109,000 | 2,832,000 |
Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities | ||||||||||||||
Operating Profit | 760,000 | 305,000 | -1,100,000 | 2,088,000 | -52,000 | 698,000 | 736,000 | -1,114,000 | 1,231,000 | 59,000 | -96,000 | 482,000 | 440,000 | 609,000 |
Depreciation | 1,148,000 | 1,733,000 | 798,000 | 134,000 | 446,000 | 418,000 | 406,000 | 338,000 | 186,000 | 141,000 | 135,000 | 113,000 | 155,000 | 169,000 |
Amortisation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Tax | 201,000 | -261,000 | 148,000 | -407,000 | -42,000 | -131,000 | -202,000 | 217,000 | -202,000 | -17,000 | 12,000 | -131,000 | -127,000 | -174,000 |
Stock | 303,000 | -172,000 | -166,000 | -104,000 | 66,000 | -306,000 | 164,000 | 55,000 | 1,255,000 | 86,000 | 88,000 | -151,000 | 5,000 | 1,118,000 |
Debtors | 4,616,000 | 77,000 | -159,000 | -1,082,000 | 572,000 | 246,000 | 148,000 | 157,000 | 269,000 | 827,000 | -3,007,000 | -132,000 | 407,000 | 3,067,000 |
Creditors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accruals and Deferred Income | 409,000 | -20,614,000 | 20,250,000 | 217,000 | 202,000 | 27,000 | -450,000 | 71,000 | 404,000 | 75,000 | -109,000 | 36,000 | -11,000 | 1,024,000 |
Deferred Taxes & Provisions | 0 | -50,000 | 50,000 | 50,000 | -42,000 | 42,000 | 0 | 0 | 0 | 359,000 | 0 | 0 | -4,000 | 4,000 |
Cash flow from operations | -2,401,000 | -18,792,000 | 20,471,000 | 3,268,000 | -126,000 | 1,114,000 | 178,000 | -700,000 | 95,000 | -296,000 | 2,861,000 | 783,000 | 41,000 | -2,553,000 |
Investing Activities | ||||||||||||||
capital expenditure | ||||||||||||||
Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
cash flow from investments | ||||||||||||||
Financing Activities | ||||||||||||||
Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Group/Directors Accounts | -20,654,000 | 20,654,000 | -18,003,000 | 768,000 | 2,584,000 | 1,982,000 | 1,333,000 | 6,324,000 | 5,012,000 | 2,581,000 | 259,000 | 0 | 0 | 0 |
Other Short Term Loans | 0 | 635,000 | -635,000 | 0 | 0 | 0 | 0 | 0 | 635,000 | 0 | 0 | 0 | 0 | 635,000 |
Long term loans | 0 | -1,520,000 | 1,520,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Hire Purchase and Lease Commitments | -832,000 | -676,000 | 1,562,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
share issue | ||||||||||||||
interest | -41,000 | -53,000 | -64,000 | -36,000 | 0 | 0 | 0 | -36,000 | -45,000 | -36,000 | -36,000 | -39,000 | -36,000 | -36,000 |
cash flow from financing | -21,527,000 | 19,281,000 | -15,639,000 | 732,000 | 2,584,000 | 1,982,000 | 1,333,000 | 6,288,000 | 8,909,000 | 2,545,000 | 223,000 | -39,000 | -36,000 | 3,032,000 |
cash and cash equivalents | ||||||||||||||
cash | -24,027,000 | 1,371,000 | 1,830,000 | 3,051,000 | 2,970,000 | 2,932,000 | 1,433,000 | 2,518,000 | 8,265,000 | 2,190,000 | 3,014,000 | 2,000 | 1,000 | 8,000 |
overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
change in cash | -24,027,000 | 1,371,000 | 1,830,000 | 3,051,000 | 2,970,000 | 2,932,000 | 1,433,000 | 2,518,000 | 8,265,000 | 2,190,000 | 3,014,000 | 2,000 | 1,000 | 8,000 |
P&L
March 2023turnover
11.5m
+29%
operating profit
760k
+149%
gross margin
45.9%
+9.98%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
March 2023net assets
6m
+0.18%
total assets
7.3m
-0.73%
cash
343k
-0.99%
net assets
Total assets minus all liabilities
john bell & croyden limited company details
company number
00228331
Type
Private limited with Share Capital
industry
47730 - Dispensing chemist in specialised stores
incorporation date
February 1928
age
96
accounts
Full Accounts
ultimate parent company
previous names
savory & moore limited (October 1988)
incorporated
UK
address
merchants warehouse, castle street, manchester, M3 4LZ
last accounts submitted
March 2023
john bell & croyden limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 3 charges/mortgages relating to john bell & croyden limited. Currently there are 0 open charges and 3 have been satisfied in the past.
john bell & croyden limited Companies House Filings - See Documents
date | description | view/download |
---|